Exploration of feasible total neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma / 中华放射肿瘤学杂志
Chinese Journal of Radiation Oncology
; (6): 65-69, 2023.
Article
in Zh
| WPRIM
| ID: wpr-993152
Responsible library:
WPRO
ABSTRACT
Neoadjuvant radiotherapy and chemotherapy combined with surgery is the standard treatment for patients with locally advanced esophageal cancer, which has been widely applied in clinical practice. Clinical efficacy has also been recognized by clinicians. However, even after the completion of neoadjuvant radiotherapy and subsequent surgical treatment, some patients still have local regional recurrence or distant metastasis in a short period of time. Among them, distant metastasis has become the main failure mode of patients undergoing surgery after neoadjuvant radiotherapy and chemotherapy, indicating that this treatment remains to be further improved. Based on the experience of patients with rectal cancer benefiting from total neoadjuvant therapy, the feasibility and implementation of total neoadjuvant therapy for locally advanced esophageal cancer were discussed in this article.
Full text:
1
Database:
WPRIM
Language:
Zh
Journal:
Chinese Journal of Radiation Oncology
Year:
2023
Document type:
Article